Komori
Governance177AKohjin Bio Co.,Ltd.Materials and Chemicals

Notice Regarding Partial Amendments to the Articles of Incorporation

Subject to approval at the general meeting of shareholders, the Company will transition from a company with a Board of Corporate Auditors to a company with an Audit and Supervisory Committee. In addition, the maximum number of directors will be increased from 7 to 10, the Articles of Incorporation will be amended to accommodate a two-person structure comprising a Representative Director and Chairman and a Representative Director and President, and the Company's business objectives will be expanded.

Worth reading
78Important
Scored from 2 of 5 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
10
Directors (maximum number)
Wording
Conditional
How definitive the wording is.

Governance structure

Planned change to a company with an Audit & Supervisory Committee (currently a company with an Audit & Supervisory Board)
Number of directorsProposed change: 3 or more and no more than 10 directors (of whom no more than 5 are directors serving as Audit and Supervisory Committee members)
Committee1
An Audit & Supervisory Committee is scheduled to be established. Proportion of outside committee members: not disclosed
Changes this time

Provisions concerning Corporate Auditors and the Board of Corporate Auditors will be deleted, and provisions concerning the Audit and Supervisory Committee and directors serving as Audit and Supervisory Committee members will be newly established. The maximum number of directors will be changed from 7 to 10. The Articles of Incorporation will be amended to accommodate a two-person structure comprising a Representative Director and Chairman and a Representative Director and President. Biotechnology, analytical and testing services relating to biological specimens, and contract services will be added to the Company's business objectives.

Governance structure
ItemDetails
Corporate Governance StructurePlanned change to a company with an Audit & Supervisory Committee (currently a company with an Audit & Supervisory Board)
Number of directorsProposed change: 3 or more and no more than 10 directors (of whom no more than 5 are directors serving as Audit and Supervisory Committee members)
CommitteeAn Audit & Supervisory Committee is scheduled to be established. Proportion of outside committee members: not disclosed
Changes this timeProvisions concerning Corporate Auditors and the Board of Corporate Auditors will be deleted, and provisions concerning the Audit and Supervisory Committee and directors serving as Audit and Supervisory Committee members will be newly established. The maximum number of directors will be changed from 7 to 10. The Articles of Incorporation will be amended to accommodate a two-person structure comprising a Representative Director and Chairman and a Representative Director and President. Biotechnology, analytical and testing services relating to biological specimens, and contract services will be added to the Company's business objectives.
Items this document does not state (4)
Number of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Expansion of the Company's business activities, greater flexibility in corporate management, strengthened audit and supervisory functions of the Board of Directors, enhanced governance, faster decision-making and business execution through the delegation of authority, and improved fairness, transparency and efficiency in management.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Partial Amendments to the Articles of Incorporation | Kohjin Bio Co.,Ltd. (177A) timely disclosure | Komori